Article Versions Notes

Yuenyong I, Potue P, Maneesai P, Khamseekaew J, Manimmanakorn A, Iampanichakul M, Pakdeechote P. Tangeretin Unravels Metabolic Dysfunction-Associated Fatty Liver Disease in Rats by Enhancing the IRS/Akt Pathway. Life. 2025; 15(3):491. https://doi.org/10.3390/life15030491

Yuenyong, Ittipon, Prapassorn Potue, Putcharawipa Maneesai, Juthamas Khamseekaew, Apiwan Manimmanakorn, Metee Iampanichakul, and Poungrat Pakdeechote. 2025. "Tangeretin Unravels Metabolic Dysfunction-Associated Fatty Liver Disease in Rats by Enhancing the IRS/Akt Pathway" Life 15, no. 3: 491. https://doi.org/10.3390/life15030491

Yuenyong, I., Potue, P., Maneesai, P., Khamseekaew, J., Manimmanakorn, A., Iampanichakul, M., & Pakdeechote, P. (2025). Tangeretin Unravels Metabolic Dysfunction-Associated Fatty Liver Disease in Rats by Enhancing the IRS/Akt Pathway. Life, 15(3), 491. https://doi.org/10.3390/life15030491